EUVIMEDEUVIMED entdecken
Crossref

COMPARATIVE STUDY BETWEEN INTRAVITREAL VERSUS SUBTENON INJECTION OF TRIAMCINOLONE ACETONIDE IN MANAGEMENT OF DIABETIC MACULAR OEDEMA

Abd El-Rahman, M., Abd El-badie, M., Mohamed, A.

Egyptian Journal of Clinical Ophthalmology · 2019

DOI: 10.21608/ejco.2019.162985 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Egyptian Journal of Clinical Ophthalmology, 2019. Verfasst von Abd El-Rahman und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To study the difference in the both safety and efficacy of Intravitreal (IVTA)versussubtenon (STTA ) triamcinolone acetonide injection as a treatment approach of diabetic macularedema (DME). Patients and Methods: 50 eyes of 38 diabetic patients diagnosed DMEaccording to the ETDRS criteria were divided into two groups; each group consists of twentyfive eyes. Group A were injected IVTA with 4 mg (0.1ml). Group B were injected STTA with 40mg (1ml).

Results

In group Awe found that the mean central macular thickness (CMT) reducedfrom 465.6 u ± 170.8 u at the baseline level to 285.9 u ± 83.2 u,267.5 u ± 79 u and 288.4u±169.8uat 1,3 and 6 months post injection respectively. In group B we found that the mean CMTreduced from 327.65u ± 68.4 u at the baseline level to 273.2 u ± 77.9, 257.8u ± 83.6u and264.9u ±104.3uat 1.3 and 6 months post injection respectively. In group A we found that themean visual acuity (VA) was improved from 0.2 at the baseline to 0.4, 0.3 and 0.4 at 1, 3 and 6months post injection respectively. In group B we found that the mean VA was improved from0.3 at the baseline to 0.5, 0.7 and 0.7at 1.3 and 6 months post injection respectively. In group Awe found that the mean intra ocular pressure (IOP)was changed from 16.2 mmHg ±1.2 mmHgat the baseline to20.9 mmHg ±6.9 mmHg, 17.4 mmHg ±1.6 mm Hg and 17.4 mmHg ±1.6 mmHgat 1,3 and 6 months post injection respectively. In group B we found that the mean IOP waschanged from15.15mmHg ±1.8 mmHg at the baseline to15.6 mmHg ±1.8 mmHg, 15.8mmHg±1.8 mmHg and15.7 mmHg ±1.8mmHg at 1.3 and 6 months post injection respectively.

Conclusion

STTA can achieve clinical results comparable to IVTA as regards the reduction ofCMT and the improvement of VA although it achieves this effect somewhat slower.

Zitieren

APA

El-Rahman, A., M., El-badie, A., M., Mohamed, & A. (2019). COMPARATIVE STUDY BETWEEN INTRAVITREAL VERSUS SUBTENON INJECTION OF TRIAMCINOLONE ACETONIDE IN MANAGEMENT OF DIABETIC MACULAR OEDEMA. Egyptian Journal of Clinical Ophthalmology. https://doi.org/10.21608/ejco.2019.162985

Vancouver

El-Rahman A, M., El-badie A, M., Mohamed, A.. COMPARATIVE STUDY BETWEEN INTRAVITREAL VERSUS SUBTENON INJECTION OF TRIAMCINOLONE ACETONIDE IN MANAGEMENT OF DIABETIC MACULAR OEDEMA. Egyptian Journal of Clinical Ophthalmology. 2019. doi:10.21608/ejco.2019.162985

BibTeX
@article{ElRahman2019,
  author = {El-Rahman, Abd and M. and El-badie, Abd and M. and Mohamed and A.},
  title = {COMPARATIVE STUDY BETWEEN INTRAVITREAL VERSUS SUBTENON INJECTION OF TRIAMCINOLONE ACETONIDE IN MANAGEMENT OF DIABETIC MACULAR OEDEMA},
  journal = {Egyptian Journal of Clinical Ophthalmology},
  year = {2019},
  doi = {10.21608/ejco.2019.162985}
}
Kostenlos starten →